Furthermore, COX-2 is involved in NASH-liver carcinogenesis because its expression level increases in precancerous stage liver diseases, such as NASH and cirrhosis, inducing the subsequent onset of liver cancer49,50. Here, PTGS2 is linked to metabolic dysfunction-associated steatohepatitis.